HGH vs MME

ASX Financial Services sector comparison — updated 14 Jul 2026 — Financial Services sector

HGH

HEARTLAND FPO NZX [HGH]

51MEDIUM

MME

MONEYME FPO [MME]

52MEDIUM

Score Breakdown

HGH MME
Technical
73
41
Catalyst
51
55
Sentiment
50
50
Fundamental
94
94
Momentum
73
52
Risk Gate
42
42

Key Metrics

HGH Metric MME
$1.0BMarket Cap$68.3M
5KAvg Volume (20d)824K
N/AShort InterestN/A
$1.11052-Week High$0.155
$0.72552-Week Low$0.075
+0.5%Daily Change-2.4%
$1.010Reference Price$0.082
+6.7%ROE-39.0%
+27.2%Profit MarginN/A

Active Signals

HGH Signals

Bollinger squeeze with volume pouring in — this is the kind of setup that often precedes a big move
Trading above both moving averages — the trend is your friend here
Volume surging at 33.2x normal while price climbs — real buying conviction behind this move
Watch out — volume is flowing out even as price holds up. Distribution pattern
Knocking on the door of resistance — if it punches through, things could get interesting
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive

MME Signals

Stochastic turning bearish from a high level — caution
Volume surging at 2.4x normal while price falls — heavy selling pressure
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Strong revenue growth (+164%)
EPS estimates revised upward (+10pts)
Near 52-week low (11% of range)

Ask Scout AI to compare HGH and MME in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

HGH vs NCC →HGH vs PPS →HGH vs RMC →HGH vs WTL →HLI vs JDO →
HGH Full Analysis → MME Full Analysis → Financial Services Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).